OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 39 filers reported holding OHR PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $6,000 | -53.8% | 68,000 | -4.2% | 0.00% | – |
Q3 2018 | $13,000 | 0.0% | 71,000 | +7.6% | 0.00% | – |
Q2 2018 | $13,000 | -13.3% | 66,000 | 0.0% | 0.00% | – |
Q1 2018 | $15,000 | -87.0% | 66,000 | +6.5% | 0.00% | – |
Q4 2017 | $115,000 | +161.4% | 62,000 | +1.6% | 0.00% | – |
Q3 2017 | $44,000 | +18.9% | 61,000 | +5.2% | 0.00% | – |
Q2 2017 | $37,000 | +270.0% | 58,000 | +404.3% | 0.00% | – |
Q1 2017 | $10,000 | -41.2% | 11,500 | 0.0% | 0.00% | – |
Q4 2016 | $17,000 | -48.5% | 11,500 | 0.0% | 0.00% | – |
Q3 2016 | $33,000 | +3.1% | 11,500 | 0.0% | 0.00% | – |
Q2 2016 | $32,000 | +60.0% | 11,500 | +88.5% | 0.00% | – |
Q1 2016 | $20,000 | -70.6% | 6,100 | -44.5% | 0.00% | -100.0% |
Q4 2015 | $68,000 | +300.0% | 11,000 | +83.3% | 0.00% | – |
Q3 2015 | $17,000 | – | 6,000 | +5900.0% | 0.00% | – |
Q1 2015 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
Q4 2014 | $1,000 | -92.9% | 100 | -93.3% | 0.00% | – |
Q2 2014 | $14,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GARRISON BRADFORD & ASSOCIATES INC | 85,415 | $55,000 | 0.05% |
Leisure Capital Management | 65,199 | $42,000 | 0.04% |
SABBY MANAGEMENT, LLC | 681,300 | $436,000 | 0.03% |
Cutter & CO Brokerage, Inc. | 44,975 | $29,000 | 0.01% |
SALZHAUER MICHAEL | 35,715 | $23,000 | 0.01% |
Cannell & Co. | 292,858 | $187,000 | 0.01% |
Tower Research Capital LLC (TRC) | 70,933 | $45,000 | 0.01% |
JT Stratford LLC | 10,000 | $6,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 15,086 | $10,000 | 0.00% |
STONERIDGE INVESTMENT PARTNERS LLC | 14,952 | $10,000 | 0.00% |